Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine



   glycine encephalopathy
  

Disease ID 165
Disease glycine encephalopathy
Definition
An autosomal recessive metabolic disorder caused by deficiencies in the mitochondrial GLYCINE cleavage system.
Synonym
disorder of glycine cleavage enzyme complex
encephalopathies, glycine
encephalopathy, glycine
gce
glycine encephalopathies
hyperglycinemia, non-ketotic
hyperglycinemia, nonketotic
hyperglycinemia, nonketotic [disease/finding]
hyperglycinemias, non-ketotic
hyperglycinemias, nonketotic
nkh
nkh - non-ketotic hyperglycinaemia
nkh - non-ketotic hyperglycinemia
non ketotic hyperglycinaemia
non ketotic hyperglycinemia
non-ketotic hyperglycinaemia
non-ketotic hyperglycinemia
non-ketotic hyperglycinemia (disorder)
non-ketotic hyperglycinemias
nonketotic hyperglycinemia
nonketotic hyperglycinemias
Orphanet
OMIM
DOID
ICD10
UMLS
C0751748
MeSH
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:5)
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:3)
2731  |  GLDC  |  CLINVAR;CTD_human;GHR;UNIPROT
275  |  AMT  |  CLINVAR;CTD_human;GHR;UNIPROT
2653  |  GCSH  |  CLINVAR;CTD_human
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:3)
275  |  AMT  |  CIPHER;CTD_human
2653  |  GCSH  |  CIPHER;CTD_human
2731  |  GLDC  |  CIPHER;CTD_human
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:54)
34  |  ACADM  |  2.392  |  DISEASES
55811  |  ADCY10  |  3.255  |  DISEASES
501  |  ALDH7A1  |  2.068  |  DISEASES
415  |  ARSE  |  1.85  |  DISEASES
546  |  ATRX  |  1.22  |  DISEASES
388962  |  BOLA3  |  4.287  |  DISEASES
875  |  CBS  |  2.38  |  DISEASES
1431  |  CS  |  1.876  |  DISEASES
1491  |  CTH  |  1.743  |  DISEASES
1557  |  CYP2C19  |  1.136  |  DISEASES
1644  |  DDC  |  2.549  |  DISEASES
8890  |  EIF2B4  |  3.338  |  DISEASES
2108  |  ETFA  |  2.291  |  DISEASES
2170  |  FABP3  |  1.172  |  DISEASES
2235  |  FECH  |  1.581  |  DISEASES
2271  |  FH  |  1.56  |  DISEASES
2566  |  GABRG2  |  2.14  |  DISEASES
2617  |  GARS  |  3.337  |  DISEASES
2638  |  GC  |  1.086  |  DISEASES
2731  |  GLDC  |  7.55  |  DISEASES
2741  |  GLRA1  |  2.591  |  DISEASES
51218  |  GLRX5  |  5.261  |  DISEASES
132158  |  GLYCTK  |  4.432  |  DISEASES
10243  |  GPHN  |  2.143  |  DISEASES
2903  |  GRIN2A  |  1.172  |  DISEASES
3155  |  HMGCL  |  2.548  |  DISEASES
200205  |  IBA57  |  3.291  |  DISEASES
152789  |  JAKMIP1  |  3.554  |  DISEASES
3785  |  KCNQ2  |  3.398  |  DISEASES
8242  |  KDM5C  |  2.405  |  DISEASES
3908  |  LAMA2  |  1.464  |  DISEASES
51601  |  LIPT1  |  4.736  |  DISEASES
4099  |  MAG  |  1.201  |  DISEASES
219541  |  MED19  |  2.523  |  DISEASES
27247  |  NFU1  |  2.901  |  DISEASES
4942  |  OAT  |  1.358  |  DISEASES
4948  |  OCA2  |  5.298  |  DISEASES
5053  |  PAH  |  1.586  |  DISEASES
5091  |  PC  |  1.897  |  DISEASES
57526  |  PCDH19  |  3.355  |  DISEASES
26227  |  PHGDH  |  1.474  |  DISEASES
5575  |  PRKAR1B  |  2.933  |  DISEASES
6334  |  SCN8A  |  1.984  |  DISEASES
6513  |  SLC2A1  |  2.377  |  DISEASES
348932  |  SLC6A18  |  3.04  |  DISEASES
9152  |  SLC6A5  |  4.172  |  DISEASES
6536  |  SLC6A9  |  4.534  |  DISEASES
10479  |  SLC9A6  |  2.537  |  DISEASES
84679  |  SLC9A7  |  2.79  |  DISEASES
6812  |  STXBP1  |  2.135  |  DISEASES
6834  |  SURF1  |  2.081  |  DISEASES
6888  |  TALDO1  |  3.124  |  DISEASES
51347  |  TAOK3  |  2.277  |  DISEASES
55503  |  TRPV6  |  1.875  |  DISEASES
Locus(Waiting for update.)
Disease ID 165
Disease glycine encephalopathy
Integrated Phenotype
HPO | Name(Total Integrated Phenotypes:13)
HP:0002353  |  EEG abnormality
HP:0100247  |  Recurrent singultus
HP:0001250  |  Seizures
HP:0010851  |  EEG with burst suppression
HP:0002079  |  Hypoplasia of the corpus callosum
HP:0012705  |  Abnormal metabolic brain imaging by MRS
HP:0001254  |  Lethargy
HP:0002154  |  Hyperglycinemia
HP:0011398  |  Central hypotonia
HP:0002033  |  Poor suck
HP:0002123  |  Generalized myoclonic seizures
HP:0005957  |  Breathing dysregulation
HP:0005972  |  Respiratory acidosis
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:4)
HP:0001298  |  Encephalopathy  |  3
HP:0001250  |  Seizures  |  1
HP:0200134  |  Epileptic encephalopathy  |  1
HP:0001289  |  Confusion  |  1
Disease ID 165
Disease glycine encephalopathy
Manually Symptom
UMLS  | Name(Total Manually Symptoms:2)
C0596992  |  myelinopathy
C0027765  |  neurologic disorder
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:1)
C1096063  |  intractable epilepsy  |  1
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
Text Mining Genotype(Total Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:112)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs11619229010873393275AMTumls:C0751748UNIPROTBiochemical and molecular investigations of patients with nonketotic hyperglycinemia.0.3631813582000AMT349419325CT
rs121964974NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96588417CA
rs121964975NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96554716GAA-
rs121964976112865062731GLDCumls:C0751748UNIPROTRecurrent mutations in P- and T-proteins of the glycine cleavage complex and a novel T-protein mutation (N145I): a strategy for the molecular investigation of patients with nonketotic hyperglycinemia (NKH).0.3746017792001GLDC96589230CT,G
rs121964976NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96589230CT,G
rs121964977152364132731GLDCumls:C0751748BeFreeThree of four nonketotic hyperglycinemia patients homozygous for a novel GLDC mutation (A802V) were treated by assisted respiration and/or sodium benzoate with or without ketamine and had transient neonatal or absent symptoms and normal developmental outcome, despite persisting biochemical evidence of nonketotic hyperglycinemia.0.3746017792004GLDC96553420GA
rs121964977NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96553420GA
rs121964978NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96645498AG
rs121964979NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96595109GA
rs121964980NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96554768CT
rs121964981NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT349419042CT
rs121964982NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT;NICN1349422223CT,A
rs121964983NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT;NICN1349422237TC
rs121964984NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT349419022CG
rs121964985NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT349417892CT
rs121964986NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT349419382GA
rs181134220NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT349417974CT
rs386833516NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96604643-A
rs386833517NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96604637GC,A
rs386833518NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96604592T-
rs386833519NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96602153GC
rs386833520NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96595100G-
rs386833521NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96592982GA
rs386833522NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96592966-TTTG
rs386833523NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96592933AT
rs386833524NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96592870CT
rs386833525NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96592224CG
rs386833526NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96592180-C
rs386833527NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96588688GC
rs386833528NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96588686TA
rs386833529NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96588629TC
rs386833530NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96645324CG
rs386833531NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96587205GA
rs386833532NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96587159ACCTGGTCATA-
rs386833533NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96587159AC
rs386833534NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96565353CT
rs386833535NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96558680CA
rs386833536NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96558659TC
rs386833537NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96558615GA
rs386833538NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96556275CG
rs386833539NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96556257GC
rs386833540NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96556250GA
rs386833541NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96556200GATTAAACCAGGA
rs386833542NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96556173CG
rs386833543NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96556169G-
rs386833544NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96556159AT
rs386833545NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96554783TC
rs386833546NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96554770AC-
rs386833547NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96554726TG
rs386833549NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96554703CT,G
rs386833550NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96554700CT
rs386833551NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96554691GA
rs386833552NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96554678GA
rs386833553NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96554673CT
rs386833554NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96553510CT
rs386833555NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96553501TC
rs386833556NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96553457GA
rs386833557NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96553411CT
rs386833558NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96553403T-
rs386833559NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96645255AC
rs386833560NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96550883GA
rs386833561NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96550853AT
rs386833562NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96550851CG
rs386833563NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96645244CT
rs386833564NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96540142AG,C
rs386833565NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96540109GT
rs386833566NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96540077TA
rs386833567NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96540060GA
rs386833568NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96536059CT
rs386833569NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96534789CG
rs386833570NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96534781GA
rs386833571NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96534758AG
rs386833572NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96534735-T
rs386833573NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96534731TC
rs386833574NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96645472G-
rs386833575NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96534707CT
rs386833576NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96620259GC,A
rs386833577NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96620241TA
rs386833578NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96620205TG
rs386833579NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96620197CA
rs386833580NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96610345TC
rs386833581NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96610314CG
rs386833582NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96610267GT
rs386833583NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96610222GA
rs386833583214113533918LAMC2umls:C0751748BeFreeA 9-year-old boy with learning disability and intermittent choreoathetosis during febrile illnesses had elevated plasma glycine level and CSF/plasma glycine ratio (0.044) and a novel homozygous missense mutation (c.605C>T; p.Ala202Val) in the GLDC gene, confirming the diagnosis of NKH.0.0005428842011GLDC96610222GA
rs386833583214113531437CSF2umls:C0751748BeFreeA 9-year-old boy with learning disability and intermittent choreoathetosis during febrile illnesses had elevated plasma glycine level and CSF/plasma glycine ratio (0.044) and a novel homozygous missense mutation (c.605C>T; p.Ala202Val) in the GLDC gene, confirming the diagnosis of NKH.0.0005428842011GLDC96610222GA
rs386833583214113532731GLDCumls:C0751748BeFreeA 9-year-old boy with learning disability and intermittent choreoathetosis during febrile illnesses had elevated plasma glycine level and CSF/plasma glycine ratio (0.044) and a novel homozygous missense mutation (c.605C>T; p.Ala202Val) in the GLDC gene, confirming the diagnosis of NKH.0.3746017792011GLDC96610222GA
rs386833584NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96610192CT,A
rs386833585NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96606599GC,A
rs386833586NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96605199G-
rs386833587NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96605186GA
rs386833588NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96605184CA
rs386833589NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96605145CG
rs386833590NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96605130CA
rs386833591NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96604759AC
rs386833592NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96604709CT,G,A
rs386833593NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96604661GT
rs386833678NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT;NICN1349422214C-
rs386833679NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT;NICN1349422145GA
rs386833680NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT;NICN1349422132GA
rs386833681NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT349421573CG
rs386833682NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT349420248TA
rs386833683NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT349420216TGAGGGCCAAATCTT-
rs386833684NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT349420209AG
rs386833685NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT349419725G-
rs386833689NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT349419282TC
rs386833690NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT349417964CT
rs386833691NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT349417879CAT-
rs386833692NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT349417868GCA
rs386833859NA2653GCSHumls:C0751748CLINVARNA0.243452799NAGCSH1681082964CA
rs772871471NA2731GLDCumls:C0751748CLINVARNA0.374601779NAGLDC96587249GC
rs797045082NA275AMTumls:C0751748CLINVARNA0.363181358NAAMT349418978CT
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)
Mapped by lexical matching(Total Items:3)
HP ID HP Name MP ID MP Name Annotation
HP:0011398Central hypotoniaMP:0004144hypotoniadecreased muscle tension resulting in limpness of the muscles in the resting state, not to be confused with weakness
HP:0002123Generalized myoclonic seizuresMP:0009358environmentally induced seizuresseizure activity response due to changes in ambient habitat including room temperature, lighting, sounds, touching, and/ or moving cage
HP:0002079Hypoplasia of the corpus callosumMP:0012129failure of blastocyst formationinability to form a blastocyst from a solid ball of cells known as a morula
Mapped by homologous gene(Total Items:12)
HP ID HP Name MP ID MP Name Annotation
HP:0005957Breathing dysregulationMP:0013205abnormal nonmotile primary cilium morphologyany structural anomaly of a primary cilium which contains a variable array of axonemal microtubules but does not contain molecular motors; nonmotile primary cilia are found on many different cell types and function as sensory organelles that concentrate a
HP:0002079Hypoplasia of the corpus callosumMP:3000003abnormal Ebner's gland morphologyany structural anomaly of the serous salivary glands which reside adjacent to the moats surrounding the circumvallate and foliate papillae just anterior to the posterior third of the tongue, anterior to the terminal sulcus; these exocrine glands secrete l
HP:0002123Generalized myoclonic seizuresMP:0020301short tonguedecreased length of the mobile mass of muscular tissue and surrounding epithelial tissue occupying the cavity of the mouth and forming part of the floor
HP:0010851EEG with burst suppressionMP:0014178increased brain apoptosisincrease in the number of cells of the brain undergoing programmed cell death
HP:0001250SeizuresMP:3000003abnormal Ebner's gland morphologyany structural anomaly of the serous salivary glands which reside adjacent to the moats surrounding the circumvallate and foliate papillae just anterior to the posterior third of the tongue, anterior to the terminal sulcus; these exocrine glands secrete l
HP:0002353EEG abnormalityMP:0020214susceptible to malignant hyperthermiaincreased susceptibility to hyperthermia triggered by exposure to certain drugs used for general anesthesia, specifically the volatile anesthetic agents and the neuromuscular blocking agent, succinylcholine
HP:0001254LethargyMP:0020137decreased bone mineralizationdecrease in the rate at which minerals are deposited into bone
HP:0002033Poor suckMP:0020137decreased bone mineralizationdecrease in the rate at which minerals are deposited into bone
HP:0011398Central hypotoniaMP:0020137decreased bone mineralizationdecrease in the rate at which minerals are deposited into bone
HP:0002154HyperglycinemiaMP:0013293embryonic lethality prior to tooth bud stagedeath prior to the appearance of tooth buds (Mus: E12-E12.5)
HP:0005972Respiratory acidosisMP:0011846decreased kidney collecting duct numbersmaller than expected number of the kidney ducts that collect urine from the distal convoluted tubules, merge and become larger as they descend from the renal cortex into the medulla, and respond to vasopressin and aldosterone to regulate water, electroly
HP:0100247Recurrent singultusMP:0011380enlarged brain ventriclesincreased size of one or more of the four communicating cavities within the brain that are continuous with the central canal of the spinal cord
Disease ID 165
Disease glycine encephalopathy
Case(Waiting for update.)